Skip to Main Content

Paper Details

A Single-center, Real-world Experience of Chronic GVHD Treatment Using Ibrutinib, Imatinib, and Ruxolitinib and its Treatment Outcomes.
Hematol Oncol Stem Cell Ther
1
2023
Author NameAffiliation
Ivan PasicPrincess Margaret Cancer Centre, University Health Network
Ivan PasicUniversity of Toronto
  • 1 - 2

Datasets

Release 1.2